Controlled release of bioactive agents in gene therapy and tissue engineering

Date

2003-01-01

Author

Keskin, DS
Hasırcı, Vasıf Nejat

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

207
views

0
downloads

Even though the drugs are effective in the treatment of some diseases, they may be inefficient or incapable of solving the problem in some other diseases. It is known that some diseases have genetic causes and therefore the search for a therapy in these cases is intense. The solutions involving either direct application of a gene or its basic product, proteins, especially the growth factors, are oftencontemplated. Gene therapy is a novel approach to treating diseases based on modifying the expression of a person’s genes toward a therapeutic goal. While genes and proteins offer a great opportunity for the treatment of many diseases their administration require critical consideration of the structure and conditions. When the conventional methods of drug administration is adopted for the administration of genes and proteins the results are not successful. Genetic material and the proteins are too labile or unstable due to their fragile 3-D structures and this makes their administration to a medium for long periods in unprotected form impossible. For gene delivery in vivo, additional problems have to be overcome, including the anatomical size constraints, protection from nonspecific interactions with body fluids, extracellular matrix and nontarget cells.

Subject Keywords

Delivery, Complexes, Polymer, Bone, Copolymers, Adenovirus, Prospects, Systems, Design, Growth, Gene therapy, Tissue engineering, Gene delivery, Tissue engineer, Tissue engineering application

URI

https://hdl.handle.net/11511/55223

Journal

TISSUE ENGINEERING, STEM CELLS AND GENE THERAPIES

Collections

Graduate School of Natural and Applied Sciences, Article

Suggestions

OpenMETU
Core

Synthesis and characterization of fatty acid based hyperbranched polymers for anti-cancer drug delivery Güç, Esra; Gündüz, Ufuk; Department of Biology (2008) Conventional methods of chemotherapy requires novel therapy systems due to serious side effects and inefficiency of drug administration. In recent years many studies are carried out to improve drug delivery systems. Polymers are one of the most important elements for drug delivery research due to their versatility. By the discovery of dendritic polymers, drug delivery studies gained a new vision. Highly branched monodisperse structure, multiple sites of attachment, well-defined size and controllable physica...
Surface functionalization of SBA - 15 particles for amoxicillin delivery Sevimli, Filiz F; Yılmaz, Ayşen; Department of Chemistry (2011) There are several studies in order to control drug delivery, decrease the toxicity of drugs and also for novel biomedical applications. It is necessary to be able to control the release of the drug within the body by using drug delivery systems. Mesoporous silica compounds have only been discovered twenty years ago and they have already attracted many researchers to study these materials for several applications. SBA-15 particles have a highly ordered regular structure and are a good matrix for guest-host a...
Tailoring magnetic PLGA nanoparticles suitable for doxorubicin delivery Tansik, Gulistan; YAKAR, ARZU; Gündüz, Ufuk (2013-12-07) One of the main problems of current cancer chemotherapy is the lack of selectivity of anti-cancer drugs to tumor cells, which leads to systemic toxicity and adverse side effects. In order to overcome these limitations, researches on controlled drug delivery systems have gained much attention. Nanoscale-based drug delivery systems provide tumor targeting. Among many types of nanocarriers, superparamagnetic nanoparticles with their biocompatible polymer coatings can be targeted to an intented site by an exter...
Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line Mutlu, Pelin; Gündüz, Ufuk (Elsevier BV, 2012-4) Drug resistance remains a major obstacle to the successful use of chemotherapeutic drugs for many types of cancers including multiple myeloma. It is becoming increasingly apparent that tumor microenvironment could provide a shelter to malignant plasma cells that allow their survival after initial drug exposure. This study demonstrates alterations in gene expression levels of several extracellular matrix (ECM) components in prednisone, vincristine and melphalan-resistant RPMI-8226 myeloma cells. Resistant RP...
INTEGRATIVE NETWORK MODELLING OF DRUG RESPONSES IN CANCER FOR REVEALING MECHANISM OF ACTION Ünsal Beyge, Şeyma; Tunçbağ, Nurcan; Department of Medical Informatics (2021-9-6) Classification of cancer drugs is crucial for drug repurposing since the cost and innovation deficit make new drug development processes challenging. Heterogeneity of cancer causes drug classification purely based on known mechanism of action (MoA) and the list of target proteins to be insufficient. Multi-omic data integration is necessary for a systems biology perspective to understand molecular mechanisms and interactions between cellular entities underlying the disease. This study integrates drug-target ...

Citation Formats

D. Keskin and V. N. Hasırcı, “Controlled release of bioactive agents in gene therapy and tissue engineering,” TISSUE ENGINEERING, STEM CELLS AND GENE THERAPIES, pp. 279–296, 2003, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/55223.